Parisa Honarpisheh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Parisa Honarpisheh has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Louise D. McCullough
Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, USA
2 shared publications - Pedram Honarpisheh
Department of Neurology, University of Texas McGovern Medical School , Houston, TX
2 shared publications - Abdullah A. Mamun
Department of Neurology, University of Texas John P. and Kathrine G. McGovern Medical School, Houston, TX, USA
1 shared publication Aditya Kumar
Department of Neurology, University of Texas McGovern Medical School , Houston, TX
1 shared publicationAmy L. Hazen
University of Texas McGovern Medical School, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases , Houston, TX
1 shared publicationAnik Banerjee
University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences , Houston, TX
1 shared publication
Latest Publications
- 15 July 2022
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 209 (2) , 288-300
CD11bhigh B Cells Increase after Stroke and Regulate Microglia
Recent studies have highlighted the deleterious contributions of B cells to post-stroke recovery and cognitive decline. Different B cell subsets have been proposed on the basis of expression levels of transcription factors (e.g., T-bet) as well as specific surface proteins. CD11b (α-chain of integrin) is expressed by several immune cell types and is involved in regulation of cell motility, phagocytosis, and other essential functions of host immunity. Although B cells express CD11b, the CD11bhigh subset of B cells has not been well characterized, especially in immune dysregulation seen with aging and after stroke. Here, we investigate the role of CD11bhigh B cells in immune responses after stroke in young and aged mice. We evaluated the ability of CD11bhigh B cells to influence pro- and anti-inflammatory phenotypes of young and aged microglia (MG). We hypothesized that CD11bhigh B cells accumulate in the brain and contribute to neuroinflammation in aging and after stroke. We found that CD11bhigh B cells are a heterogeneous subpopulation of B cells predominantly present in naive aged mice. Their frequency increases in the brain after stroke in young and aged mice. Importantly, CD11bhigh B cells regulate MG phenotype and increase MG phagocytosis in both ex vivo and in vivo settings, likely by production of regulatory cytokines (e.g., TNF-α). As both APCs and adaptive immune cells with long-term memory function, B cells are uniquely positioned to regulate acute and chronic phases of the post-stroke immune response, and their influence is subset specific. Key Points CD11bhigh B cells are a distinct subset of B cells that increase with aging. CD11bhigh B cells are increased in both young and aged brains after stroke. CD11bhigh B cells can regulate microglia phenotypes and increase phagocytosis.
- 15 July 2022
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 209 (2) , 288-300
CD11bhigh B Cells Increase after Stroke and Regulate Microglia
Recent studies have highlighted the deleterious contributions of B cells to post-stroke recovery and cognitive decline. Different B cell subsets have been proposed on the basis of expression levels of transcription factors (e.g., T-bet) as well as specific surface proteins. CD11b (α-chain of integrin) is expressed by several immune cell types and is involved in regulation of cell motility, phagocytosis, and other essential functions of host immunity. Although B cells express CD11b, the CD11bhigh subset of B cells has not been well characterized, especially in immune dysregulation seen with aging and after stroke. Here, we investigate the role of CD11bhigh B cells in immune responses after stroke in young and aged mice. We evaluated the ability of CD11bhigh B cells to influence pro- and anti-inflammatory phenotypes of young and aged microglia (MG). We hypothesized that CD11bhigh B cells accumulate in the brain and contribute to neuroinflammation in aging and after stroke. We found that CD11bhigh B cells are a heterogeneous subpopulation of B cells predominantly present in naive aged mice. Their frequency increases in the brain after stroke in young and aged mice. Importantly, CD11bhigh B cells regulate MG phenotype and increase MG phagocytosis in both ex vivo and in vivo settings, likely by production of regulatory cytokines (e.g., TNF-α). As both APCs and adaptive immune cells with long-term memory function, B cells are uniquely positioned to regulate acute and chronic phases of the post-stroke immune response, and their influence is subset specific. Key Points CD11bhigh B cells are a distinct subset of B cells that increase with aging. CD11bhigh B cells are increased in both young and aged brains after stroke. CD11bhigh B cells can regulate microglia phenotypes and increase phagocytosis.
- Open Access
- 1 December 2020
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 17 (1) , 1-13
Potential caveats of putative microglia-specific markers for assessment of age-related cerebrovascular neuroinflammation
Background: The ability to distinguish resident microglia from infiltrating myeloid cells by flow cytometry-based surface phenotyping is an important technique for examining age-related neuroinflammation. The most commonly used surface markers for the identification of microglia include CD45 (low-intermediate expression), CD11b, Tmem119, and P2RY12.Methods: In this study, we examined changes in expression levels of these putative microglia markers in in vivo animal models of stroke, cerebral amyloid angiopathy (CAA), and aging as well as in an ex vivo LPS-induced inflammation model.Results: We demonstrate that Tmem119 and P2RY12 expression is evident within both CD45intand CD45highmyeloid populations in models of stroke, CAA, and aging. Interestingly, LPS stimulation of FACS-sorted adult microglia suggested that these brain-resident myeloid cells can upregulate CD45 and downregulate Tmem119 and P2RY12, making them indistinguishable from peripherally derived myeloid populations. Importantly, our findings show that these changes in the molecular signatures of microglia can occur without a contribution from the other brain-resident or peripherally sourced immune cells.Conclusion: We recommend future studies approach microglia identification by flow cytometry with caution, particularly in the absence of the use of a combination of markers validated for the specific neuroinflammation model of interest. The subpopulation of resident microglia residing within the “infiltrating myeloid” population, albeit small, may be functionally important in maintaining immune vigilance in the brain thus should not be overlooked in neuroimmunological studies.
- 1 December 2020
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 17 (1) , 1-13
Open AccessPotential caveats of putative microglia-specific markers for assessment of age-related cerebrovascular neuroinflammation
Background: The ability to distinguish resident microglia from infiltrating myeloid cells by flow cytometry-based surface phenotyping is an important technique for examining age-related neuroinflammation. The most commonly used surface markers for the identification of microglia include CD45 (low-intermediate expression), CD11b, Tmem119, and P2RY12.Methods: In this study, we examined changes in expression levels of these putative microglia markers in in vivo animal models of stroke, cerebral amyloid angiopathy (CAA), and aging as well as in an ex vivo LPS-induced inflammation model.Results: We demonstrate that Tmem119 and P2RY12 expression is evident within both CD45intand CD45highmyeloid populations in models of stroke, CAA, and aging. Interestingly, LPS stimulation of FACS-sorted adult microglia suggested that these brain-resident myeloid cells can upregulate CD45 and downregulate Tmem119 and P2RY12, making them indistinguishable from peripherally derived myeloid populations. Importantly, our findings show that these changes in the molecular signatures of microglia can occur without a contribution from the other brain-resident or peripherally sourced immune cells.Conclusion: We recommend future studies approach microglia identification by flow cytometry with caution, particularly in the absence of the use of a combination of markers validated for the specific neuroinflammation model of interest. The subpopulation of resident microglia residing within the “infiltrating myeloid” population, albeit small, may be functionally important in maintaining immune vigilance in the brain thus should not be overlooked in neuroimmunological studies.